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Mutation of solute carrier SLC16A12 associates with a syndrome
combining juvenile cataract with microcornea and renal
glucosuria
Abstract
Unobstructed vision requires a particular refractive index of the lens, a measure based on the
organization of the structural proteins within the differentiated lens cells. To ensure an intact lens
structure, homeostasis within the lens cells is indispensable. Alterations of the lens structure result in
opacity and lead to cataract. Renal glucosuria is defined by elevated glucose level in the urine without
hyperglycemia and without evidence of morphological renal anomalies. In a Swiss family with
autosomal dominant juvenile cataract, microcornea, and renal glucosuria, we have identified a nonsense
mutation in a member of the carboxylic acid transporter family SLC16. The underlying gene defect in
SLC16A12 resides within a 3 cM region on chromosome 10q23.13 defined by linkage mapping of this
phenotype. We found tissue-specific variability of SLC16A12 transcript levels in control samples, with
high expression in the eye and kidney, the two organs affected by this syndrome. This report
demonstrates biological relevance of this solute carrier. We hypothesize that SLC16A12 is important for
lens and kidney homeostasis and discuss its potential role in age-related cataract.
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Abstract 1 
Unobstructed vision requires a particular refractive index of the lens, a measure based 2 
on the organization of the structural proteins within the differentiated lens cells.  To 3 
ensure an intact lens structure, homeostasis within the lens cells is indispensable. 4 
Alterations of the lens structure result in opacity and lead to cataract.  Renal 5 
glucosuria is defined by elevated glucose level in the urine without hyperglycemia 6 
and without evidence of morphological renal anomalies.  In a Swiss family with 7 
autosomal dominant juvenile cataract, microcornea and renal glucosuria, we have 8 
identified a nonsense mutation in a member of the carboxylic acid transporter family 9 
SLC16A.  The underlying gene defect in SLC16A12 resides within a 3 cM region on 10 
chromosome 10q23.13 defined by linkage mapping of this novel phenotype. We 11 
found tissue-specific variability of SLC16A12 transcript levels in control individuals, 12 
with high expression in the eye and kidney, the two organs affected by this novel 13 
syndrome.  This is the first report of the biological relevance of this solute carrier.  14 
We hypothesize that SLC16A12 is important for lens and kidney homeostasis and 15 
discuss its potential role in age-related cataract.  16 
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Lens transparency, a requirement of unobstructed vision, is achieved by ordered 1 
events of cell differentiation accompanied with controlled arrangement of proteins, 2 
mainly crystallins.  Differentiation of the lens cells follows a precise sequence of 3 
events 1. Mitotic activity of a small number of lens epithelial cells (LEC) provides a 4 
continuous supply of new cells that, upon signal induced differentiation will begin 5 
with a cellular elongation process, followed by the breakdown of the nucleus and 6 
organelles. Concomitantly, some but not all metabolic activity ceases.  Tightly 7 
packed, highly elongated cells comprise the several millimeter thick lens structure.  8 
Changes in this structure, composition or the assembly of the structural proteins, of 9 
which crystallines make about 90%, will result in alteration of the refractive index. 10 
This increasing opacity of the lens is termed cataract. Defined by age of onset, one 11 
distinguishes between congenital (infantile), juvenile, and age-related cataract. The 12 
first two, also referred to as childhood cataract, show wide heterogeneity with respect 13 
to the genetic and phenotypic aspects 2. Frequently, mutations that disturb the 14 
development of the lens occur in structural lens proteins and will lead to childhood 15 
cataract.  Among the genetic factors that influence age-related cataract, no genes with 16 
mutations have yet been identified.  Genes involved in recessively or dominantly 17 
inherited cataract encode structural components of the lens cells but also components 18 
of the cytoskeleton, of the cell membrane, transcription factors, metabolic proteins, 19 
chromatin modifying protein -4B and the gene TMEM114, encoding a protein with 4 20 
predicted transmembrane domains but of unknown function 3,4,5,6.  21 
Occasionally, cataract is accompanied by additional symptoms, among them 22 
microcornea 4,5.  Of particular interest to this work is a Swiss family with juvenile 23 
cataract, associated with microcornea and renal glucosuria 7.  While renal glucosuria 24 
is not considered a disease, affected individuals show characteristic elevation of 25 
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glucose concentration in the urine, without evidence of renal tubular defects.  The 1 
pattern of inheritance has been described as codominant with variable penetrance 8.  2 
In the family described by Vandekerckhove and colleagues, 9 of 12 cataract patients 3 
also showed elevated levels of glucose in their urine, in the absence of any other renal 4 
or metabolic abnormalities (fig.1, 2 and table 1). 5 
To determine the underlying genetic defect and whether cataract and glucosuria are 6 
caused by the same pathogenic alteration was subject of this study.  We began with 7 
linkage analysis using the Affymetrix GeneChip Human Mapping 10K Array, version 8 
2.0 (Affymetrix, Santa Clara, CA). Nonparametric linkage analysis using all 9 
genotypes of a chromosome simultaneously was carried out with MERLIN and 10 
parametric linkage analysis was performed by the program ALLEGRO 9 assuming a 11 
disease allele frequency of 0.0001 and autosomal dominant inheritance with full 12 
penetrance for cataract. Haplotypes were reconstructed with ALLEGRO and 13 
presented graphically with HaploPainter 10. Results predicted that the disease causing 14 
mutation for the juvenile cataract and microcornea maps to an interval on 15 
chromosome 10q23.31 (fig. 3) of 3 cM, spanning between the SNP markers rs701826 16 
and rs2254391(fig. 4).  For the glucosuria phenotype no significant LOD score was 17 
obtained (data not shown), probably due to low penetrance. Calculations of 50% 18 
penetrance for affected patients revealed a LOD score slightly above 2 on a region of 19 
chromosome 10, which overlaps with the 3 cM interval for cataract.  These findings 20 
suggest that more affected family members are required to obtain a significant LOD 21 
score for glucosuria. 22 
The NCBI map viewer (Build 36.2, August 2007) displayed 31 genes and 3 known 23 
phenotypes (selection shown in Table 2) within the linkage interval on Chromosome 24 
10q23.31.  Among the phenotypes, none seemed obviously related to cataract.  Distal 25 
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to this linkage interval maps the homeobox gene PITX3 (MIM-602669).  Mutations in 1 
this gene are known to cause the dominant form of congenital cataract and anterior 2 
segment mesenchymal dysgenesis (ASMD) 11,12.  We performed sequence analysis in 3 
the DNA of one affected patient (II-1) without finding a mutation (data not shown; 4 
primer sequences are available upon request).   5 
Considering the function of each of the 31 genes within the linkage interval, we 6 
reasoned, that FAS and SLC16A12 were potential candidate genes.  FAS, (MIM- 7 
134637) encoding the tumor necrosis factor receptor super family member 6, could 8 
play a role during differentiation of lens cells 13.  DNA sequence analysis did not 9 
reveal a coding region mutation, but upstream of the transcription unit, we detected a 10 
deletion of six thymidin residues. Since this alteration was also found in unaffected 11 
family members it was excluded as disease causing.  In addition, a deletion of seven 12 
thymidin residues at the same site has been reported as SNP rs3074157.   13 
Metabolic requirements of the lens cells can be accommodated by establishing a 14 
transport system for small molecules.  The gene encoding the solute carrier 15 
SLC16A12 (ENSG00000152779, NCBI GeneID: 387700) belongs to a family of 14 16 
monocarboxylate transporters 14.  All members display an average size of 40-50 kDa 17 
and are characterized by 12 transmembrane domains (TMDs). Besides DNA sequence 18 
and gene annotation for SLC16A12, no information on its genetic and biochemical 19 
properties was available.  We sequenced the five coding exons (3 to 8) including 20 
approximately 50-100 base pairs of their respective flanking introns and UTR regions 21 
and found a heterozygous mutation in exon 6: c.643C>T, which is predicted to lead to 22 
a premature termination codon p.Q215X (fig. 5). This mutation was found in all 12 23 
cataract patients of the Swiss family while the three unaffected individuals (II/11, III/9 24 
and III/11) did not carry this alteration.  It was also absent in 370 normal alleles, two 25 
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of which were from an unrelated spouse of the family (II/10) (fig 1).  Thus, we 1 
considered SLC16A12 as the gene associated with the development of cataract.  2 
Knowledge of the expression pattern of SLC16A12 would aid in understanding its 3 
effect on cataract with microcornea and glucosuria.  For that purpose, we performed 4 
RT-PCR experiments based on established procedures 15 with RNA from several 5 
organs, including the two affected structures, lens and kidney (fig. 6).  In general, the 6 
solute carrier was detected in retina, brain, lung, kidney, liver and testis, although at 7 
remarkably different levels. We compared the amount of SLC16A12 transcripts with 8 
that of the endogenous control transcripts from RNA polymerase II gene, and 9 
estimated that the solute carrier seemed most highly expressed in kidney, followed by 10 
retina, lung and testis and very weakly in brain and liver (fig. 6B).  The expected RT-11 
PCR fragment was not detected in blood cells (data not shown).  In addition, we 12 
assayed SLC16A12 transcripts isolated from human retina, retinal pigment epithelial 13 
cells (RPE) and lens of a 47 year old eye donor lacking any signs of cataract and 14 
confirmed the expression pattern we had seen from purchased RNA (fig. 6B and C).  15 
Importantly, SLC16A12 transcripts were also detected in the human lens (fig. 6C). 16 
Since only a very small portion of the lens, namely the lens epithelial cells (LECs), 17 
may be transcriptionally active, we concluded that expression of SLC16A12 in the 18 
LECs must be relatively high. Our RT-PCR data show that SLC16A12 expression is 19 
regulated in a cell/tissue -specific manner.  These observations concur with the 20 
reported expression pattern of other SLC16A family members, which can be either 21 
ubiquitous or tissue-specific 16,14.  Tissue-specific regulation of SLC16A12 expression 22 
is further supported by the lack of additional manifesting symptoms in the Swiss 23 
family.   24 
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This report provides first evidence for the physiological function of SLC16A12.  In 1 
combination with the knowledge of the transport function of other SLC16A isoforms, 2 
a prediction of molecular activity is possible. These transporters are highly conserved 3 
throughout evolution and can be found in prokaryotes as well as eukaryotes, from 4 
yeast to mammals.  They can transport lactate, aromatic amino acids, short-chain fatty 5 
acids, butyrate, ketones or thyroid hormone in a proton-dependent or -independent 6 
fashion 14.  Sub-cellular localization of some family members in the eye and also 7 
kidney points to highly specific tasks of molecular transport 17,18.  Although neither 8 
the localization in the lens or kidney, nor substrate specificity of this transporter is 9 
known, we speculate that its reduction would interfere with homeostasis. In the lens, 10 
solutes need to move from the cortical lens epithelial cells to the inner fiber cells.  In 11 
the kidney, solutes also need to move between tubular cells and blood.   12 
Prediction of membrane topology 19 revealed a 536 amino acid protein containing 12 13 
transmembrane domains (TMDs) with both termini located intracellularly. While the 14 
large intra-cellular loop and both termini show high variability in their amino acid 15 
sequence among the different SLC16A family members, highest conservation is found 16 
in the 1st and 5th TMD 14.  The p.Q215X mutation in SLC16A12 is located within the 17 
large cytoplasmic loop near the fourth TMD (fig. 7), predicted to result in a truncated 18 
protein with severely impaired or completely absent transport function.  The 19 
premature termination codon might cause mRNA decay of the mutant allele, possibly 20 
by the mechanism of nonsense mediated decay 20, but a dominant negative effect or 21 
gain of function of the truncated protein can not be excluded.  Consequently, reduced 22 
amounts of the normal allele in the patients could account for a gradual, progressive 23 
nature of the cataract.  The resulting deficiency in transportation of metabolites in the 24 
lens could lead to alteration of structural components of the fiber cells and the 25 
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refractive index, contributing to the development of cataract.  Similarly, defective 1 
transport in the kidney could lead to excessive accumulation of glucose in the urine, 2 
making SLC16A12, directly or indirectly, involved in glucose transport.  Since the 3 
causes of glucosuria can be heterogeneous, other factors, singly or in combination 4 
with deficient SLC transporter activity, could result in the highly variable phene of 5 
glucosuria.  6 
Although several arguments have been presented that support a model, in which 7 
cataract and glucosuria are caused by the same mutation, we can not rule out that the 8 
two diseases may segregate independently. In case of an unlinked locus for 9 
glucosuria, examples of potential candidates include the caperone protein CD147, 10 
which facilitates subcellular sorting of  SLC16A members 17 or proteins involved in 11 
glucose transportation, i.e.GLUT proteins 21 or SLC5A2 8.     12 
Age-related cataract, which is the most common cause for avoidable blindness 13 
worldwide, is known to be dependent on both, environmental risk factors and genetic 14 
factors. A twin study on the cortical type of age-related cataract implies the action of 15 
dominant genes to account for genetic heritability of about 50% 22,23.  The progressive 16 
course of juvenile cataract described here, resulting most likely from defective 17 
transport of small molecules, suggests the potential role of the SLC16A12 transporter 18 
in age-related cataracts as well. Depending on the type and location of mutations 19 
within the SLC16A12 transporter, more or less severe forms of cataract would be 20 
expected, which may also vary in the time of onset. We propose that mutations in a 21 
solute carrier such as SLC16A12 could lead to the age-related form of cataract.  22 
Knowledge of the substrate may open new venues for non-surgical treatment.   23 
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Taken together, we show for the first time the biological relevance of the solute 1 
carrier SLC16A12 and suggest a function in the establishment and/or maintenance of 2 
homeostasis in the lens and probably also in the kidney.    3 
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Figure Legends 1 
Figure 1 2 
Pedigree of Swiss family segregating juvenile cataract with microcornea and 3 
glucosuria (modified after 7).   Dark filled symbols represent affected status for all 4 
three phenotypes, with three exceptions indicated by star; III-1 and III-2 are negative, 5 
III-5 is borderline for glucosuria (table 1). Five-digit laboratory identification numbers 6 
(given below pedigree symbols) were assigned prior to DNA extraction. Family 7 
members IV-2 and IV-3 were not tested for any of the three phenotypes.    8 
 9 
Figure 2 10 
Cataract and microcornea phenotype of patient III-5.  Pre-operative cortico-nuclear 11 
cataract in right eye is shown in (A) and microcornea (9.8 x 9.5 mm) in (B).   12 
 13 
Figure 3 14 
LOD scores across the genome for the phenotype of cataract with microcornea. 15 
Chromosome number and genetic distances in cM (centi Morgan) is horizontally 16 
displayed; LOD score is given along the vertical axis.   17 
 18 
Figure 4 19 
Haplotypes for the cataract-linked region on chromosome 10.  Recombinations in 20 
patients 26808 (III-4) and 26274 (IV-1) define a critical interval of 2.6 Mega bases 21 
(Mb) delimited by markers SNP_A_1510595 (rs701826) (*) and SNP_A_1511227 22 
(rs2254391) (**) at positions 108.48 and 111.55 cM, respectively.  Disease 23 
chromosome in red.   24 
 25 
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Figure 5 1 
Mutation screening in SCL16A12.  Electropherogram shows the mutation in exon 6 2 
within the context of 21 nucleotides. The DNA sequence of the unaffected individual 3 
III-9 is displayed to the left, while the heterozygous change of C>T (Y) in the affected 4 
individual III- 8 is shown to the right.  The genotypes are given in brackets. 5 
Translation codons are underlined and amino acid identity is written below using 6 
single letter code.   7 
 8 
Figure 6   9 
Expression studies of SLC16A12. (A) Schematic representation of exons. Protein 10 
coding regions are displayed in darker shade.  Translation initiates within exon 3 11 
(vertical arrow, ATG) and terminates within exon 8 (vertical arrow, STOP).  12 
Mutation, c.643C>T, in exon 6 (vertical arrow) is predicted to lead to a premature 13 
termination. Positions of primers are indicated by forward and reverse horizontal 14 
arrows, yielding RT-PCR product a (exon spanning 4_5 to exon 6) and product b 15 
(exon 3 to exon 5).  (B) RT-PCR analyses from human tissues with commercially 16 
available mRNA.  Primers to yield product a were used to amplify SLC16A12 17 
transcripts.  RNA Polymerase II transcripts served as endogenous control.  (C) RT-18 
PCR analysis from tissues isolated from a single human donor eye.   Primers to yield 19 
product b of SLC16A12 and RNA Polymerase II gene (control) were used for 20 
amplification.  Lens RNA was three-fold concentrated compared to the other samples.   21 
 22 
Figure 7 23 
Schematic representation of the predicted secondary structure of SLC16A12.  24 
Prediction of membrane topology revealed a 536 amino acid protein with 12 25 
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transmembrane domains separated by intra and extra cellular domains of varying 1 
lengths with both termini (NH2 and COOH) located intracellularly.  Amino acid 2 
glutamin (Gln, Q) at position 215 is mutated to a stop in the patients described herein 3 
(red circle).  4 
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Table 1.  Summary of clinical data   1 
Pedigree ID Cataract Microcornea 
 
Glucosuria 
 
II-1 + + + 
II-3 + + + 
II-5 + + + 
II-7 + + + 1) 
II-9 + + + 
II-11 - - - 
III-1 + + - 1) 
III-2 + + - 
III-4 + + + 
III-5 + + +/- 2) 
III-7 + + + 
III-8 + + + 
III-9 - - + 3) 
III-11 - - - 
 2 
Pedigree identification numbers are taken from Figure 1.  Presence/absence of 3 
cataract, microcornea and renal glucosuria is given as +/-. Assignment of microcornea 4 
was given if values were below 11.0mm. Glucosuria was evaluated as positive (+) if 5 
glucose concentration was above 0.8 mmol/L.  Glucose values were generally 6 
obtained from postprandial samples except for patients II-7 and III-11).  2) test 7 
performed during pregnancy; 3) borderline value.  8 
 9 
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Table 2.  Phenotype and loci that map to the linkage interval on chromosome 10. 1 
 2 
Symbol Description MIM Position 
 phenotypes   
TNFRSF6 tumor necrosis factor receptor 
superfamily, member 6 
134637 10q24.1 
LIPA Wolman disease, liposomal acid lipase 
deficiency 
278000 10q24-
q25 
SCZD11 schizophrenia susceptibility locus 608078 10q22.3 
    
 Loci MIM or Ensembl GeneID 
LIPF lipase, gastric 601980 8513 
LIPK lipase, family member K ENSG00000204021 643414 
LIPN member N ENSG00000204020 643418 
LIPM member M ENSG00000173239 340654 
ANKRD22 ankyrin repeat domain 22 ENSG00000152766 118932 
STAMBPL1 STAM binding protein-like 1 ENSG00000138134 57559 
ACTA2 actin, alpha 2, smooth muscle,  ENSG00000107796 59 
FAS Fas (TNF receptor superfamily, 
member 6) 
134637 355 
CH25H cholesterol 25-hydroxylase 604551 9023 
LIPA lipase A, (Wolman disease) 278000 3988 
IFIT2 interferon-induced protein with 
tetratricopeptide repeats 2 
147040 3433 
IFIT3 repeats 3 604650 3437 
IFIT1L repeats 1-like ENSG00000204010 439996 
IFIT1 repeats 1 147690 3434 
IFIT5 repeats 5 ENSG00000152778 24138 
SLC16A12 solute carrier family 16, member 12 
(monocarboxylic acid transporter 12) 
ENSG00000152779 387700 
MIRN107 microRNA 107  406901 
PANK1 pantothenate kinase 1 606160 53354 
MPHOSPH1 M-phase phosphoprotein 1 605498 9585 
HTR7 5-hydroxytryptamine (serotonin) 
receptor 7 (adenylate cyclase-coupled) 
182137 3363 
RPP30 ribonuclease P/MRP 30kDa subunit 606115 10556 
ANKRD1 ankyrin repeat domain 1 (cardiac 
muscle) 
609599 27063 
NUDT9P1 nudix (nucleoside diphosphate linked 
moiety X)-type motif 9 pseudogene 1 
 119369 
PCGF5 polycomb group ring finger 5 ENSG00000180628 84333 
HECTD2 HECT domain containing 2 ENSG00000165338 143279 
PPP1R3C protein phosphatase 1, regulatory 
(inhibitor) subunit 3C 
602999 5507 
TNKS2 tankyrase, TRF1-interacting ankyrin-
related ADP-ribose polymerase 2 
607128 80351 
 3 
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From the NCBI map viewer (Build 36.2, August 2007) selected 27 annotated genes 1 
and all phenotypes located to the affected region on chromosome 10q23.31 are 2 
shown. For identification, MIM code, Ensembl code or GeneID ( NCBI) is given. 3 
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Table 3.  Primer information  1 
gene - exon - direction sequence purpose 
SLC16A12 ex3f gtctgccccagtctagtattca Genomic sequencing 
SLC16A12 ex3r cggaaatacacacacaccaca Genomic sequencing 
SLC16A12 ex4f ccctgtggtggttgaacact Genomic sequencing 
SLC16A12 ex4r tggctttggctgaagatagg Genomic sequencing 
SLC16A12 ex5f tctattccaaccctgctgct Genomic sequencing 
SLC16A12 ex5r ccagctctgtttaactgctagg Genomic sequencing 
SLC16A12 ex6af gaatgactggtgaggggaga Genomic sequencing 
SLC16A12 ex6ar aacagaacggagacggctaa Genomic sequencing 
SLC16A12 ex6bf cggggagccttactcattct Genomic sequencing 
SLC16A12 ex6br agtaccagcaagggagatgc Genomic sequencing 
SLC16A12 ex7f cacaatgggaaagccatctc Genomic sequencing 
SLC16A12 ex7r atggttttgggggctcttat Genomic sequencing 
SLC16A12 ex8f caaagttacaattggtggtgct Genomic sequencing 
SLC16A12 ex8r agttatgagcacaaatcccaaa Genomic sequencing 
SLC16A12exon3f caggaagtcactggacagca RT-PCR 
SLC16A12exon5r caggaagtcactggacagca RT-PCR 
SLC16A12exon4_5f gtgtgaccatgctctgtgct RT-PCR 
SLC16A12exon6r aagacaaagcccccaagaat RT-PCR 
RPII_cDNA_N20_F tgtggagatcttcacggtgct RT-PCR 
RPII_cDNA_N234_R cataagcacgtccaccgtttc RT-PCR 
 2 
The name of primers contains information about the gene (SLC16A12 or RNA 3 
polymerase II (RPII), exon and direction, forward (f,F) or reverse(r,R).  The sequence 4 
of primers points 5’ to 3’.  Primers were used to amplify genomic DNA for sequence 5 
analysis or for transcript analysis in RT-PCR experiments.   6 
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